Latham Guides Boston Scientific's Heart Catheter Maker Buy

Law360, New York (September 19, 2012, 4:35 PM EDT) -- Boston Scientific Corp. is buying BridgePoint Medical Inc., the manufacturer of a proprietary catheter system that restores blood flow to blocked arteries, from a consortium of private equity owners to boost its position in the medical device market, it announced Wednesday.

BridgePoint's system treats an ailment known as coronary chronic total occlusions, or CTOs, and is expected to significantly amp up Boston Scientific's interventional cardiology business. Pending closing conditions, the deal with the Minnesota-based manufacturer — whose investors include New Enterprise Associates, Polaris Venture Partners, Foundation...
To view the full article, register now.